Philip J. Vickers

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Stacia Kargman, Gary P. O’Neill, Philip J. Vickers et al. · PubMed · 1995 · 836 citations

Chemoprevention Strategy, Immunology, Pathology +16

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

Richard A. F. Dixon, Ronald E. Diehl, Evan E. Opas et al. · Nature · 1990 · 775 citations

Biosynthesis, Oxysterol, Biochemistry +6

Identification and isolation of a membrane protein necessary for leukotriene production

Douglas K. Miller, John W. Gillard, Philip J. Vickers et al. · Nature · 1990 · 462 citations

Proteinlipid Interaction, Biosynthesis, Biochemistry +11

The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

Petpiboon Prasit, Z Wang, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 426 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Active Cyclooxygenase-2 Inhibitor +10

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.

John Woods, Jilly F. Evans, Diane Ethier et al. · The Journal of Experimental Medicine · 1993 · 395 citations · Full text

Proteinlipid Interaction, Activated Human Leukocytes, Lipid Peroxidation +22